NSD2-induced H3K36me2 also upregulates key enzymes in glucose metabolism, including hexokinase 2 (HK2) and glucose-6-phosphoate dehydrogenase (G6PD), in endocrine therapy-resistant cancer cells [137]. The gene discussed is HK2; the disease is cancer.